Medical Director/Clinical Trial Physician - Neurology(FSP)
Thermo Fisher Scientific- Internship
- Mid-level (3 to 4 years), Senior (5 to 8 years)
Employment Type: Full-time
Salary: $275,000 - $310,000 (This range is applicable if the role is performed from Illinois and may vary for other locations such as California, Colorado, New York. Actual salary may vary based on qualifications and experience.)
Location Type: [Not Specified]
Passionate about precision medicine and advancing the healthcare industry? Tempus is seeking a Medical Director, Tempus Studies, to join our medical science team. This role is crucial for overseeing high-priority observational and interventional studies within the Tempus AI Studies group. As the primary clinical expert, you will be responsible for study design, protocol development, and study execution, collaborating with multidisciplinary teams and representing Tempus externally to biopharma collaborators and clinical researchers. You will also provide critical medical input to advance various Tempus AI initiatives by collaborating with other business units within the organization.
Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
[Not Specified]
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.